Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 29Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Triple Negative Breast Neoplasms 15Lung Neoplasms 10Colorectal Neoplasms 8Neoplasm Metastasis 7Esophageal Squamous Cell Carcinoma 7Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Ovarian Neoplasms 4Biliary Tract Neoplasms 4Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Pancreatic Ductal 3Vaccinia 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms by Site 2Neoplasms 2Locally Advanced Pancreatic Cancer 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Advanced Solid Tumors 2Adenocarcinoma 2Ureteral Neoplasms 1Thyroid Neoplasms 1Squamous Non-small Cell Lung Cancer 1

Interventions

relacorilant 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Fallopian Tube Diseases × 130-nm albumin-bound paclitaxel × Clear all
NCT06906341 2026-04-14

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Corcept Therapeutics

Phase 2 Recruiting
270 enrolled
Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡